Industry Research Reports

Home > Reports > Chemical & Material > Nedaplatin API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Nedaplatin API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Chemical & Material

Published Date: 2024-02-19

Pages: 88 Pages

Report ld: 2528306

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Nedaplatin API was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

Nedaplatin is a platinum-based antineoplastic drug which is used for cancer chemotherapy. Nedaplatin is a second generation platinum analog . It is less nephrotoxic than DB00515 but has proven equally effective.

MARKET SEGMENTATION

By Company

Nanjing Hairun Pharmaceutical
Simcere
Qilu Pharma
Jilin Hengjin Pharmaceutical

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Purity ≥98%
Purity ≥99%

Segment by Application

Lung Cancer
Esophageal Cancer
Bladder Cancer
Testicular Cancer
Ovarian Cancer
Cervical Cancer
Other

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Nedaplatin API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Nedaplatin API by region & country, by Type, and by Application.

The Nedaplatin API market size, estimations, and forecasts are provided in terms of sales volume (Ton) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nedaplatin API.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Nedaplatin API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Nedaplatin API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Nedaplatin API in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Nedaplatin API Product Introduction

1.2 Global Nedaplatin API Market Size Forecast

1.2.1 Global Nedaplatin API Sales Value (2019-2030)

1.2.2 Global Nedaplatin API Sales Volume (2019-2030)

1.2.3 Global Nedaplatin API Sales Price (2019-2030)

1.3 Nedaplatin API Market Trends & Drivers

1.3.1 Nedaplatin API Industry Trends

1.3.2 Nedaplatin API Market Drivers & Opportunity

1.3.3 Nedaplatin API Market Challenges

1.3.4 Nedaplatin API Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Nedaplatin API Players Revenue Ranking (2023)

2.2 Global Nedaplatin API Revenue by Company (2019-2024)

2.3 Global Nedaplatin API Players Sales Volume Ranking (2023)

2.4 Global Nedaplatin API Sales Volume by Company Players (2019-2024)

2.5 Global Nedaplatin API Average Price by Company (2019-2024)

2.6 Key Manufacturers Nedaplatin API Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Nedaplatin API Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Nedaplatin API

2.9 Nedaplatin API Market Competitive Analysis

2.9.1 Nedaplatin API Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Nedaplatin API Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nedaplatin API as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Purity ≥98%

3.1.2 Purity ≥99%

3.2 Global Nedaplatin API Sales Value by Type

3.2.1 Global Nedaplatin API Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Nedaplatin API Sales Value, by Type (2019-2030)

3.2.3 Global Nedaplatin API Sales Value, by Type (%) (2019-2030)

3.3 Global Nedaplatin API Sales Volume by Type

3.3.1 Global Nedaplatin API Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Nedaplatin API Sales Volume, by Type (2019-2030)

3.3.3 Global Nedaplatin API Sales Volume, by Type (%) (2019-2030)

3.4 Global Nedaplatin API Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Lung Cancer

4.1.2 Esophageal Cancer

4.1.3 Bladder Cancer

4.1.4 Testicular Cancer

4.1.5 Ovarian Cancer

4.1.6 Cervical Cancer

4.1.7 Other

4.2 Global Nedaplatin API Sales Value by Application

4.2.1 Global Nedaplatin API Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Nedaplatin API Sales Value, by Application (2019-2030)

4.2.3 Global Nedaplatin API Sales Value, by Application (%) (2019-2030)

4.3 Global Nedaplatin API Sales Volume by Application

4.3.1 Global Nedaplatin API Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Nedaplatin API Sales Volume, by Application (2019-2030)

4.3.3 Global Nedaplatin API Sales Volume, by Application (%) (2019-2030)

4.4 Global Nedaplatin API Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Nedaplatin API Sales Value by Region

5.1.1 Global Nedaplatin API Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Nedaplatin API Sales Value by Region (2019-2024)

5.1.3 Global Nedaplatin API Sales Value by Region (2025-2030)

5.1.4 Global Nedaplatin API Sales Value by Region (%), (2019-2030)

5.2 Global Nedaplatin API Sales Volume by Region

5.2.1 Global Nedaplatin API Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Nedaplatin API Sales Volume by Region (2019-2024)

5.2.3 Global Nedaplatin API Sales Volume by Region (2025-2030)

5.2.4 Global Nedaplatin API Sales Volume by Region (%), (2019-2030)

5.3 Global Nedaplatin API Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Nedaplatin API Sales Value, 2019-2030

5.4.2 North America Nedaplatin API Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Nedaplatin API Sales Value, 2019-2030

5.5.2 Europe Nedaplatin API Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Nedaplatin API Sales Value, 2019-2030

5.6.2 Asia Pacific Nedaplatin API Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Nedaplatin API Sales Value, 2019-2030

5.7.2 South America Nedaplatin API Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Nedaplatin API Sales Value, 2019-2030

5.8.2 Middle East & Africa Nedaplatin API Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Nedaplatin API Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Nedaplatin API Sales Value

6.2.1 Key Countries/Regions Nedaplatin API Sales Value, 2019-2030

6.2.2 Key Countries/Regions Nedaplatin API Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Nedaplatin API Sales Value, 2019-2030

6.3.2 United States Nedaplatin API Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Nedaplatin API Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Nedaplatin API Sales Value, 2019-2030

6.4.2 Europe Nedaplatin API Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Nedaplatin API Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Nedaplatin API Sales Value, 2019-2030

6.5.2 China Nedaplatin API Sales Value by Type (%), 2023 VS 2030

6.5.3 China Nedaplatin API Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Nedaplatin API Sales Value, 2019-2030

6.6.2 Japan Nedaplatin API Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Nedaplatin API Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Nedaplatin API Sales Value, 2019-2030

6.7.2 South Korea Nedaplatin API Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Nedaplatin API Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Nedaplatin API Sales Value, 2019-2030

6.8.2 Southeast Asia Nedaplatin API Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Nedaplatin API Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Nedaplatin API Sales Value, 2019-2030

6.9.2 India Nedaplatin API Sales Value by Type (%), 2023 VS 2030

6.9.3 India Nedaplatin API Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Nanjing Hairun Pharmaceutical

7.1.1 Nanjing Hairun Pharmaceutical Company Information

7.1.2 Nanjing Hairun Pharmaceutical Introduction and Business Overview

7.1.3 Nanjing Hairun Pharmaceutical Nedaplatin API Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Nanjing Hairun Pharmaceutical Nedaplatin API Product Offerings

7.1.5 Nanjing Hairun Pharmaceutical Recent Development

7.2 Simcere

7.2.1 Simcere Company Information

7.2.2 Simcere Introduction and Business Overview

7.2.3 Simcere Nedaplatin API Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Simcere Nedaplatin API Product Offerings

7.2.5 Simcere Recent Development

7.3 Qilu Pharma

7.3.1 Qilu Pharma Company Information

7.3.2 Qilu Pharma Introduction and Business Overview

7.3.3 Qilu Pharma Nedaplatin API Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Qilu Pharma Nedaplatin API Product Offerings

7.3.5 Qilu Pharma Recent Development

7.4 Jilin Hengjin Pharmaceutical

7.4.1 Jilin Hengjin Pharmaceutical Company Information

7.4.2 Jilin Hengjin Pharmaceutical Introduction and Business Overview

7.4.3 Jilin Hengjin Pharmaceutical Nedaplatin API Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Jilin Hengjin Pharmaceutical Nedaplatin API Product Offerings

7.4.5 Jilin Hengjin Pharmaceutical Recent Development

8 Industry Chain Analysis

8.1 Nedaplatin API Industrial Chain

8.2 Nedaplatin API Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Nedaplatin API Sales Model

8.5.2 Sales Channel

8.5.3 Nedaplatin API Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Nedaplatin API Market Trends

Table 2. Nedaplatin API Market Drivers & Opportunity

Table 3. Nedaplatin API Market Challenges

Table 4. Nedaplatin API Market Restraints

Table 5. Global Nedaplatin API Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Nedaplatin API Revenue Market Share by Company (2019-2024)

Table 7. Global Nedaplatin API Sales Volume by Company (2019-2024) & (Ton)

Table 8. Global Nedaplatin API Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Nedaplatin API Price by Company (2019-2024) & (US$/Ton)

Table 10. Key Manufacturers Nedaplatin API Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Nedaplatin API Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Nedaplatin API

Table 13. Global Nedaplatin API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nedaplatin API as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Nedaplatin API Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Nedaplatin API Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Nedaplatin API Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Nedaplatin API Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Nedaplatin API Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Nedaplatin API Sales Volume by Type: 2019 VS 2023 VS 2030 (Ton)

Table 22. Global Nedaplatin API Sales Volume by Type (2019-2024) & (Ton)

Table 23. Global Nedaplatin API Sales Volume by Type (2025-2030) & (Ton)

Table 24. Global Nedaplatin API Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Nedaplatin API Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Nedaplatin API Price by Type (2019-2024) & (US$/Ton)

Table 27. Global Nedaplatin API Price by Type (2025-2030) & (US$/Ton)

Table 28. Global Nedaplatin API Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Nedaplatin API Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Nedaplatin API Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Nedaplatin API Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Nedaplatin API Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Nedaplatin API Sales Volume by Application: 2019 VS 2023 VS 2030 (Ton)

Table 34. Global Nedaplatin API Sales Volume by Application (2019-2024) & (Ton)

Table 35. Global Nedaplatin API Sales Volume by Application (2025-2030) & (Ton)

Table 36. Global Nedaplatin API Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Nedaplatin API Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Nedaplatin API Price by Application (2019-2024) & (US$/Ton)

Table 39. Global Nedaplatin API Price by Application (2025-2030) & (US$/Ton)

Table 40. Global Nedaplatin API Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Nedaplatin API Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Nedaplatin API Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Nedaplatin API Sales Value by Region (2019-2024) & (%)

Table 44. Global Nedaplatin API Sales Value by Region (2025-2030) & (%)

Table 45. Global Nedaplatin API Sales Volume by Region (Ton): 2019 VS 2023 VS 2030

Table 46. Global Nedaplatin API Sales Volume by Region (2019-2024) & (Ton)

Table 47. Global Nedaplatin API Sales Volume by Region (2025-2030) & (Ton)

Table 48. Global Nedaplatin API Sales Volume by Region (2019-2024) & (%)

Table 49. Global Nedaplatin API Sales Volume by Region (2025-2030) & (%)

Table 50. Global Nedaplatin API Average Price by Region (2019-2024) & (US$/Ton)

Table 51. Global Nedaplatin API Average Price by Region (2025-2030) & (US$/Ton)

Table 52. Key Countries/Regions Nedaplatin API Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Nedaplatin API Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Nedaplatin API Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Nedaplatin API Sales Volume, (2019-2024) & (Ton)

Table 56. Key Countries/Regions Nedaplatin API Sales Volume, (2025-2030) & (Ton)

Table 57. Nanjing Hairun Pharmaceutical Company Information

Table 58. Nanjing Hairun Pharmaceutical Introduction and Business Overview

Table 59. Nanjing Hairun Pharmaceutical Nedaplatin API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 60. Nanjing Hairun Pharmaceutical Nedaplatin API Product Offerings

Table 61. Nanjing Hairun Pharmaceutical Recent Development

Table 62. Simcere Company Information

Table 63. Simcere Introduction and Business Overview

Table 64. Simcere Nedaplatin API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 65. Simcere Nedaplatin API Product Offerings

Table 66. Simcere Recent Development

Table 67. Qilu Pharma Company Information

Table 68. Qilu Pharma Introduction and Business Overview

Table 69. Qilu Pharma Nedaplatin API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 70. Qilu Pharma Nedaplatin API Product Offerings

Table 71. Qilu Pharma Recent Development

Table 72. Jilin Hengjin Pharmaceutical Company Information

Table 73. Jilin Hengjin Pharmaceutical Introduction and Business Overview

Table 74. Jilin Hengjin Pharmaceutical Nedaplatin API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 75. Jilin Hengjin Pharmaceutical Nedaplatin API Product Offerings

Table 76. Jilin Hengjin Pharmaceutical Recent Development

Table 77. Key Raw Materials Lists

Table 78. Raw Materials Key Suppliers Lists

Table 79. Nedaplatin API Downstream Customers

Table 80. Nedaplatin API Distributors List

Table 81. Research Programs/Design for This Report

Table 82. Key Data Information from Secondary Sources

Table 83. Key Data Information from Primary Sources

List of Figures

Figure 1. Nedaplatin API Product Picture

Figure 2. Global Nedaplatin API Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Nedaplatin API Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Nedaplatin API Sales Volume (2019-2030) & (Ton)

Figure 5. Global Nedaplatin API Sales Price (2019-2030) & (US$/Ton)

Figure 6. Nedaplatin API Report Years Considered

Figure 7. Global Nedaplatin API Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Nedaplatin API Players Sales Volume Ranking (2023) & (Ton)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Nedaplatin API Revenue in 2023

Figure 10. Nedaplatin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Purity ≥98% Picture

Figure 12. Purity ≥99% Picture

Figure 13. Global Nedaplatin API Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Nedaplatin API Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Nedaplatin API Sales Volume by Type (2019 VS 2023 VS 2030) & (Ton)

Figure 16. Global Nedaplatin API Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Nedaplatin API Price by Type (2019-2030) & (US$/Ton)

Figure 18. Product Picture of Lung Cancer

Figure 19. Product Picture of Esophageal Cancer

Figure 20. Product Picture of Bladder Cancer

Figure 21. Product Picture of Testicular Cancer

Figure 22. Product Picture of Ovarian Cancer

Figure 23. Product Picture of Cervical Cancer

Figure 24. Product Picture of Other

Figure 25. Global Nedaplatin API Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 26. Global Nedaplatin API Sales Value Market Share by Application, 2023 & 2030

Figure 27. Global Nedaplatin API Sales Volume by Application (2019 VS 2023 VS 2030) & (Ton)

Figure 28. Global Nedaplatin API Sales Volume Market Share by Application, 2023 & 2030

Figure 29. Global Nedaplatin API Price by Application (2019-2030) & (US$/Ton)

Figure 30. North America Nedaplatin API Sales Value (2019-2030) & (US$ Million)

Figure 31. North America Nedaplatin API Sales Value by Country (%), 2023 VS 2030

Figure 32. Europe Nedaplatin API Sales Value (2019-2030) & (US$ Million)

Figure 33. Europe Nedaplatin API Sales Value by Country (%), 2023 VS 2030

Figure 34. Asia Pacific Nedaplatin API Sales Value (2019-2030) & (US$ Million)

Figure 35. Asia Pacific Nedaplatin API Sales Value by Country (%), 2023 VS 2030

Figure 36. South America Nedaplatin API Sales Value (2019-2030) & (US$ Million)

Figure 37. South America Nedaplatin API Sales Value by Country (%), 2023 VS 2030

Figure 38. Middle East & Africa Nedaplatin API Sales Value (2019-2030) & (US$ Million)

Figure 39. Middle East & Africa Nedaplatin API Sales Value by Country (%), 2023 VS 2030

Figure 40. Key Countries/Regions Nedaplatin API Sales Value (%), (2019-2030)

Figure 41. Key Countries/Regions Nedaplatin API Sales Volume (%), (2019-2030)

Figure 42. United States Nedaplatin API Sales Value, (2019-2030) & (US$ Million)

Figure 43. United States Nedaplatin API Sales Value by Type (%), 2023 VS 2030

Figure 44. United States Nedaplatin API Sales Value by Application (%), 2023 VS 2030

Figure 45. Europe Nedaplatin API Sales Value, (2019-2030) & (US$ Million)

Figure 46. Europe Nedaplatin API Sales Value by Type (%), 2023 VS 2030

Figure 47. Europe Nedaplatin API Sales Value by Application (%), 2023 VS 2030

Figure 48. China Nedaplatin API Sales Value, (2019-2030) & (US$ Million)

Figure 49. China Nedaplatin API Sales Value by Type (%), 2023 VS 2030

Figure 50. China Nedaplatin API Sales Value by Application (%), 2023 VS 2030

Figure 51. Japan Nedaplatin API Sales Value, (2019-2030) & (US$ Million)

Figure 52. Japan Nedaplatin API Sales Value by Type (%), 2023 VS 2030

Figure 53. Japan Nedaplatin API Sales Value by Application (%), 2023 VS 2030

Figure 54. South Korea Nedaplatin API Sales Value, (2019-2030) & (US$ Million)

Figure 55. South Korea Nedaplatin API Sales Value by Type (%), 2023 VS 2030

Figure 56. South Korea Nedaplatin API Sales Value by Application (%), 2023 VS 2030

Figure 57. Southeast Asia Nedaplatin API Sales Value, (2019-2030) & (US$ Million)

Figure 58. Southeast Asia Nedaplatin API Sales Value by Type (%), 2023 VS 2030

Figure 59. Southeast Asia Nedaplatin API Sales Value by Application (%), 2023 VS 2030

Figure 60. India Nedaplatin API Sales Value, (2019-2030) & (US$ Million)

Figure 61. India Nedaplatin API Sales Value by Type (%), 2023 VS 2030

Figure 62. India Nedaplatin API Sales Value by Application (%), 2023 VS 2030

Figure 63. Nedaplatin API Industrial Chain

Figure 64. Nedaplatin API Manufacturing Cost Structure

Figure 65. Channels of Distribution (Direct Sales, and Distribution)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Nedaplatin API market? zhanKai

The top companies in the global Nedaplatin API market are Nanjing Hairun Pharmaceutical、Simcere、Qilu Pharma.

Related Reports

Nedaplatin API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Nedaplatin API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-09
Pages: 116
USD 3950.00
(Single User License)
Global Nedaplatin API Market Research Report 2026
The global Nedaplatin API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 120
USD 2900.00
(Single User License)
Global Nedaplatin API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Nedaplatin API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-24
Pages: 114
USD 4900.00
(Single User License)
Global Nedaplatin API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Nedaplatin API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 70
USD 4250.00
(Single User License)
Nedaplatin API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Nedaplatin API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 90
USD 3950.00
(Single User License)
Global Nedaplatin API Market Research Report 2025
The global market for Nedaplatin API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 78
USD 2900.00
(Single User License)
Global Nedaplatin API Market Insights, Forecast to 2030
The global Nedaplatin API market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-07
Pages: 76
USD 4900.00
(Single User License)
Global Nedaplatin API Market Research Report 2024
The global Nedaplatin API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-16
Pages: 76
USD 2900.00
(Single User License)

Nedaplatin API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Nedaplatin API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-09
Pages: 116
USD 3950.00 (Single User License)
Global Nedaplatin API Market Research Report 2026
The global Nedaplatin API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 120
USD 2900.00 (Single User License)
Global Nedaplatin API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Nedaplatin API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-24
Pages: 114
USD 4900.00 (Single User License)
Global Nedaplatin API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Nedaplatin API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 70
USD 4250.00 (Single User License)
Nedaplatin API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Nedaplatin API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 90
USD 3950.00 (Single User License)
Global Nedaplatin API Market Research Report 2025
The global market for Nedaplatin API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 78
USD 2900.00 (Single User License)
Global Nedaplatin API Market Insights, Forecast to 2030
The global Nedaplatin API market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-07
Pages: 76
USD 4900.00 (Single User License)
Global Nedaplatin API Market Research Report 2024
The global Nedaplatin API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-16
Pages: 76
USD 2900.00 (Single User License)